Delivery Order SPE2DX22D0010-SPE2D826FCV53
Award Date 1/30/26
Potential Completion Date 2/2/26
Potential Value $5.3K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Quillivant XR Oral Suspension 60ML 5MG/ML with a ceiling value of $6,990.30. This firm fixed-price delivery order, which is expected to be completed by August 5, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Quillivant XR 25 mg/5 mL suspension (60 mL) with a contract value of $7,625.58. The award was made on a competitive basis with no set-aside designation and carries a firm fixed price structure with an ultimate completion date of September 19, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of Quillivant XR Oral Suspension 60ML 5MG/ML, a pharmaceutical product used in the treatment of attention deficit disorders. The award, valued at $9,205.46, represents a firm fixed-price delivery order with no set-aside designation, indicating competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on October 20, 2025, for the supply of Quillivant XR Oral Suspension 60ML 5MG/ML with a ceiling value of $1,203.08. This is a firm fixed-price, non-set-aside competitive award issued by the Defense Logistics Agency's Medical Supply Chain, with an ultimate completion date of October 21, 2025. The delivery will be performed at the awardee's corporate office...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Quillivant XR 25 mg/5 ml suspension in 60 ml quantities, valued at $2,915.25. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The contract is scheduled for completion by June 3, 2025, with performance taking place at AmerisourceBergen's corporate office location in...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Quillivant XR 25 mg/5 mL suspension in 60 mL quantities, with a ceiling value of $3,991.48. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for ultimate completion by September 23, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Quillivant XR 25 mg/5 ml suspension in a 150 ml quantity, with a ceiling value of $1,383.36. This is a firm fixed price delivery order with no set-aside designation, issued competitively as part of AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The contract is scheduled for completion by July 23, 2025, with performance at the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Quillivant XR 25 mg/5 ml suspension in 150ml quantities, with a ceiling value of $5,042.70 and a firm fixed price contract type. This award was not set aside for small business or other designated groups and represents a competitively awarded delivery order under AmerisourceBergen's existing contract vehicle. The place of performance is identified as Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,626.04 to AmerisourceBergen Drug Corp for Quillivant XR 25 mg/5 ml suspension (120 ml), with an ultimate completion date of October 22, 2025. This competitively awarded, firm fixed-price contract was issued on October 21, 2025, with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $8,336.72 to AmerisourceBergen Drug Corp for the supply of Quillivant XR oral suspension 60ml 5mg/ml, with an ultimate completion date of November 12, 2025. This competitively awarded, firm fixed-price delivery order utilizes no set-aside designation and represents a pharmaceutical supply transaction typical of federal medical procurement operations. The work is to be performed at AmerisourceBergen's corporate...